Assessment of the Use of Angiotensin Receptor Blockers in Major European Markets Among Paediatric Population for Treating Essential Hypertension

Journal of Human Hypertension - United Kingdom
doi 10.1038/jhh.2008.139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparative Assessment of Angiotensin Receptor Blockers in Different Clinical Settings

Vascular Health and Risk Management
2009English

Potential Beneficial Impact of Angiotensin Receptor Blockers on Arterial Stiffness in Hypertension

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Updates on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors

Journal of Managed Care Pharmacy
2011English

Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2015English

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Current Hypertension Reports
Internal Medicine
2016English

Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2018English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy